• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Effect of Fenofibrate Therapy on Laser Treatment for Diabetic Retinopathy: A Meta-Analysis of Randomized Controlled Trials.非诺贝特治疗对糖尿病视网膜病变激光治疗的影响：一项随机对照试验的荟萃分析
Diabetes Care. 2022 Jan 1;45(1):e1-e2. doi: 10.2337/dc21-1439.
2
Fenofibrate and Diabetic Retinopathy.非诺贝特与糖尿病视网膜病变
Curr Diab Rep. 2016 Oct;16(10):90. doi: 10.1007/s11892-016-0786-7.
3
Fenofibrate - a potential systemic treatment for diabetic retinopathy?非诺贝特——一种治疗糖尿病性视网膜病变的潜在全身治疗方法？
Am J Ophthalmol. 2012 Jul;154(1):6-12. doi: 10.1016/j.ajo.2012.03.013.
4
Fenofibrate for Diabetic Retinopathy.非诺贝特治疗糖尿病视网膜病变。
Asia Pac J Ophthalmol (Phila). 2018 Nov-Dec;7(6):422-426. doi: 10.22608/APO.2018288. Epub 2018 Jul 30.
5
Fenofibrate and diabetic retinopathy.非诺贝特与糖尿病视网膜病变
Clin Exp Ophthalmol. 2015 May-Jun;43(4):297-9. doi: 10.1111/ceo.12539.
6
Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial.非诺贝特对糖尿病视网膜病变激光治疗需求的影响（FIELD研究）：一项随机对照试验。
Lancet. 2007 Nov 17;370(9600):1687-97. doi: 10.1016/S0140-6736(07)61607-9. Epub 2007 Nov 7.
7
Prevention and treatment of diabetic retinopathy: evidence from large, randomized trials. The emerging role of fenofibrate.糖尿病视网膜病变的预防与治疗：来自大型随机试验的证据。非诺贝特的新作用。
Rev Recent Clin Trials. 2012 Feb;7(1):71-80. doi: 10.2174/157488712799363299.
8
Fenofibrate for diabetic retinopathy.非诺贝特用于治疗糖尿病视网膜病变。
Lancet. 2007 Nov 17;370(9600):1667-8. doi: 10.1016/S0140-6736(07)61608-0. Epub 2007 Nov 7.
9
Effect of micronized fenofibrate on microvascular complications of type 2 diabetes: a systematic review.微粒化非诺贝特对2型糖尿病微血管并发症的影响：一项系统评价。
Expert Opin Pharmacother. 2016 Aug;17(11):1463-73. doi: 10.1080/14656566.2016.1195811. Epub 2016 Jun 15.
10
Improving Diabetic Retinopathy Outcomes: FIELD Fenofibrate.改善糖尿病视网膜病变结局：FIELD非诺贝特。
J Assoc Physicians India. 2018 Dec;66(12):55-57.

引用本文的文献

1
The prevention opportunities of retinopathy in diabetic patients - position paper endorsed by the Polish Lipid Association.糖尿病患者视网膜病变的预防机遇——波兰脂质协会认可的立场文件
Arch Med Sci. 2024 Dec 13;20(6):1754-1769. doi: 10.5114/aoms/197331. eCollection 2024.
2
Fenofibrate therapy in reducing the progression of diabetic retinopathy: revisiting the FIELD and ACCORD-EYE studies through the LENS trial.非诺贝特治疗对糖尿病视网膜病变进展的影响：通过LENS试验重新审视FIELD和ACCORD-EYE研究
Eye (Lond). 2025 Jan;39(1):15-17. doi: 10.1038/s41433-024-03410-9. Epub 2024 Oct 22.
3
Lessons from PROMINENT and prospects for pemafibrate.从 PROMINENT 研究中获得的启示和 pemafibrate 的前景。
Cardiovasc Diabetol. 2024 Jul 29;23(1):279. doi: 10.1186/s12933-024-02305-z.
4
Effect of Fenofibrate on Progression of Diabetic Retinopathy.非诺贝特对糖尿病视网膜病变进展的影响。
NEJM Evid. 2024 Aug;3(8):EVIDoa2400179. doi: 10.1056/EVIDoa2400179. Epub 2024 Jun 21.
5
Underprescription of Fibrate Among Patients With Diabetic Retinopathy in Perak, Malaysia.马来西亚霹雳州糖尿病视网膜病变患者贝特类药物处方不足情况
Cureus. 2024 Jan 1;16(1):e51434. doi: 10.7759/cureus.51434. eCollection 2024 Jan.
6
Therapeutic roles of PPARα activation in ocular ischemic diseases.过氧化物酶体增殖物激活受体α（PPARα）激活在眼部缺血性疾病中的治疗作用
Histol Histopathol. 2023 Apr;38(4):391-401. doi: 10.14670/HH-18-542. Epub 2022 Oct 28.
7
The 2022 American Diabetes Association Meeting.2022年美国糖尿病协会会议。
J Diabetes. 2022 Jul;14(7):428-433. doi: 10.1111/1753-0407.13297. Epub 2022 Jul 16.

本文引用的文献

1
Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study.2020 年失明和视力障碍的原因及 30 多年来的趋势，以及与 VISION 2020：看见的权利相关的可避免盲的患病率：全球疾病负担研究的分析。
Lancet Glob Health. 2021 Feb;9(2):e144-e160. doi: 10.1016/S2214-109X(20)30489-7. Epub 2020 Dec 1.
2
Effects of medical therapies on retinopathy progression in type 2 diabetes.医学治疗对 2 型糖尿病视网膜病变进展的影响。
N Engl J Med. 2010 Jul 15;363(3):233-44. doi: 10.1056/NEJMoa1001288. Epub 2010 Jun 29.
3
Effects of combination lipid therapy in type 2 diabetes mellitus.2 型糖尿病的联合降脂治疗效果。
N Engl J Med. 2010 Apr 29;362(17):1563-74. doi: 10.1056/NEJMoa1001282. Epub 2010 Mar 14.
4
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial.长期非诺贝特治疗对9795例2型糖尿病患者心血管事件的影响（FIELD研究）：随机对照试验
Lancet. 2005 Nov 26;366(9500):1849-61. doi: 10.1016/S0140-6736(05)67667-2.

Effect of Fenofibrate Therapy on Laser Treatment for Diabetic Retinopathy: A Meta-Analysis of Randomized Controlled Trials.

作者信息

Preiss David, Spata Enti, Holman Rury R, Coleman Ruth L, Lovato Laura, Ginsberg Henry N, Armitage Jane

机构信息

1MRC Population Health Research Unit, Clinical Trial Service Unit, and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, U.K.

2Diabetes Trials Unit, Radcliffe Department of Medicine, University of Oxford, Oxford, U.K.

出版信息

Diabetes Care. 2022 Jan 1;45(1):e1-e2. doi: 10.2337/dc21-1439.

DOI:10.2337/dc21-1439
PMID:34876531
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8753761/
Abstract
摘要